Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Drug Development Institute (IDDI) is a specialized Contract Research Organization (CRO) providing biostatistical and eClinical services to the pharmaceutical and biotechnology industries. Founded in 1991, the company focuses on optimizing the clinical development of new drugs and medical devices through expert trial design and data analysis. IDDI is particularly recognized for its expertise in oncology and ophthalmology, offering services such as randomization (IWRS), data management, and statistical consultancy. The company operates globally with offices in Belgium and the United States, supporting clinical trials from Phase I through Phase IV.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Drug Discovery Institute.